Javier Guillermo
Cassinello Espinosa
Profesor/a Asociado/a en CC. de la Salud
Hospital General Universitario Gregorio Marañón
Madrid, EspañaPublications in collaboration with researchers from Hospital General Universitario Gregorio Marañón (15)
2022
-
A phase II randomised trial of abiraterone acetate plus prednisone in combination with docetaxel or docetaxel plus prednisone after disease progression to abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer: The ABIDO-SOGUG trial
European Journal of Cancer, Vol. 175, pp. 110-119
2020
-
Latest progress in molecular biology and treatment in genitourinary tumours
Clinical and Translational Oncology, Vol. 22, Núm. 12, pp. 2175-2195
2018
-
Consensus statement on definition, diagnosis, and management of high-risk prostate cancer patients on behalf of the Spanish Groups of Uro-Oncology Societies URONCOR, GUO, and SOGUG
Clinical and Translational Oncology, Vol. 20, Núm. 3, pp. 392-401
-
Correction to: SEOM clinical guidelines for the treatment of metastatic prostate cancer (2017) (Clinical and Translational Oncology, (2018), 20, 1, (57-68), 10.1007/s12094-017-1783-2)
Clinical and Translational Oncology
-
Preliminary safety results of the randomized phase II ABIDO-SOGUG trial: Toxicity profile of concomitant abiraterone acetate + docetaxel treatment in comparison to docetaxel
Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii286
-
SEOM clinical guidelines for the treatment of metastatic prostate cancer (2017)
Clinical and Translational Oncology, Vol. 20, Núm. 1, pp. 57-68
2016
-
Quality indicators to assure and improve cancer care in Spain using the delphi technique
JNCCN Journal of the National Comprehensive Cancer Network, Vol. 14, Núm. 5, pp. 553-558
-
Retrospective analysis of metastatic non-clear cell renal carcinoma (NCCRC): the Spanish Grupo Centro Experience
Annals of Oncology, Vol. 27, pp. vi290
-
SEOM Clinical Guideline for bone metastases from solid tumours (2016)
Clinical and Translational Oncology, Vol. 18, Núm. 12, pp. 1243-1253
2015
-
Updated recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with metastatic castration-resistant prostate cancer
Critical Reviews in Oncology/Hematology, Vol. 96, Núm. 2, pp. 308-318
2012
-
Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with metastatic castration-resistant prostate cancer
Critical Reviews in Oncology/Hematology, Vol. 83, Núm. 3, pp. 341-352
-
SEOM clinical guidelines for treatment of prostate cancer
Clinical and Translational Oncology, Vol. 14, Núm. 7, pp. 520-527
-
Treatment of cancer pain: Spanish Society of Medical Oncology (SEOM) recommendations for clinical practice
Clinical and Translational Oncology, Vol. 14, Núm. 7, pp. 499-504
2009
-
Adjuvant chemotherapy for stages II, III and IV of colon cancer
Clinical and Translational Oncology, Vol. 11, Núm. 8, pp. 526-533
2007
-
Update in the management of ovarian and cervical carcinoma
Clinical and Translational Oncology, Vol. 9, Núm. 7, pp. 443-451